One dose of COVID-19 nanoparticle vaccine REVC-128 provides protection against SARS-CoV-2 challenge at two weeks post immunization

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Biochemistry

Chemistry

Immunology

Microbiology

Show all topics

DOI

10.1101/2021.04.02.438218

License

CC-BY-NC-ND

Other Formats

PDF